Table of Contents
DUBLIN, Ireland — Endo International plc has shipped what it calls the first and only generic 2% topical testosterone gel.
The company said Monday that the product, an authorized generic version of Fortesta Gel, is distributed by Qualitest and promoted by Endo Pharmaceuticals Inc.
Endo Pharmaceuticals continues to be responsible for the distribution and promotion of 2% Fortesta Gel.
Fortesta Gel and its authorized generic version are approved by the Food and Drug administration to treat adult men with low or no testosterone, or hypogonadism.
"We believe the launch of the authorized generic of 2% Fortesta Gel will help expand access to this important therapy for men who are diagnosed with hypogonadism," stated Rajiv De Silva, president and chief executive offie of Endo. "In addition, we expect this launch will create the opportunity to maximize the value of our Fortesta franchise while also enhancing the commercial partnership opportunities between our branded and generics business segments."
